For instance, a six-month PPT1 mimetic treatment significantly reduced microglial activation in Ppt1−/− mice, a model of Infantile Neuronal Ceroid Lipofuscinosis (45). This evidence concerns the gene PPT1 and neuronal ceroid lipofuscinosis.